Cellectar Biosciences Inc - Company Profile

Powered by

All the sales intelligence you need on Cellectar Biosciences Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Cellectar Biosciences Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Cellectar Biosciences Inc.

Back to companies

Cellectar Biosciences Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Cellectar Biosciences Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Cellectar Biosciences Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Douglas J. Swirsky

Chairman Executive Board Since: 2017 Age: 55

Mr. Douglas J. Swirsky has been the Chairman of the company since 2017. Prior to this, he served as the President and Chief Executive Officer of GenVec Inc. from 2014 to June 2017. He also held multiple roles at GenVec from 2006 to 2014, including Chief Financial Officer, Senior Vice President, Treasurer, and Corporate Secretary. Previously, he worked at Stifel Nicolaus as the Head of Life Sciences Investment Banking and as a Managing Director. He also held investment banking positions at PaineWebber, Morgan Stanley, UBS, and Legg Mason. In addition to his role as Chairman, he is the President and Chief Executive Officer of Rexahn Pharmaceuticals Inc. and serves on the boards of Pernix Therapeutics Holdings Inc. and Fibrocell Science Inc.

Read Hide full bio of Douglas J. Swirsky

James V. Caruso

Chief Executive Officer; Director; President Executive Board Since: 2015 Age: 66

Mr. James V. Caruso has been the Chief Executive Officer, President, and Director of the company since 2015. Prior to this, he served as the Executive Vice President and Chief Operating Officer at HIP Innovation Technology, LLC. Previously, he served as the Executive Vice President and Chief Commercial Officer at Allos Therapeutics, Inc., and as Senior Vice President of Sales and Marketing at Bone Care International, Inc. Mr. Caruso also served as the Vice President of Neuroscience Specialty Sales at Novartis, Vice President of Primary Care and Specialty Sales at BASF Pharmaceuticals-Knoll, and various senior sales and marketing roles at Bristol-Myers Squibb Company.

Read Hide full bio of James V. Caruso

Chad J. Kolean

Vice President; Chief Financial Officer; Secretary Senior Management Since: 2022 Age: 60

Mr. Chad J. Kolean has been the Chief Financial Officer, Secretary, and Vice President of the company since 2022. Prior to this, he served as the Chief Financial Officer and Treasurer at Pioneer Surgical Technology. His career includes various roles at Tomotherapy, Inc., Metavante Corporation, Snap-On, Inc., Herman Miller, Inc., Kaydon Corporation, and Arthur Andersen LLP.

Read Hide full bio of Chad J. Kolean

Jarrod Longcor

Chief Operating Officer Senior Management Since: 2022 Age: 52

Mr. Jarrod Longcor has been the Chief Operating Officer of the company since 2022. Prior to this, he served as the Chief Business Officer of the company since September 2017. Previously, he served as the Chief Business Officer at Avillion LLP. Mr. Longcor also served as the Vice President of Corporate Development at Rib-X Pharmaceuticals, Inc.

Read Hide full bio of Jarrod Longcor

John Neis

Director Non Executive Board Since: 2008 Age: 69
Gain a 360-degree view of Cellectar Biosciences Inc and make more informed decisions for your business Gain a 360-degree view of Cellectar Biosciences Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer